Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT06344052
Title To Assess the Safety and Efficacy of SP-002 With Vismodegib for the Treatment of Locally Advanced Basal Cell Carcinoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Stamford Pharmaceuticals, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Research Site NOT_YET_RECRUITING Phoenix Arizona 85006 United States Details
Research Site NOT_YET_RECRUITING Lee's Summit Missouri 64064 United States Details
Research Site RECRUITING Cedar Park Texas 78613 United States Details
Research Site NOT_YET_RECRUITING Humble Texas 77346 United States Details
Research Site NOT_YET_RECRUITING Longview Texas 75601 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field